Cite
HARVARD Citation
Vermersch, P. et al. (2022). 015 Reduced risk of secondary progressive multiple sclerosis by treatment with clad- ribine tablets: CLARITY study analysis. Journal of neurology, neurosurgery and psychiatry. 93 (6), p. A18. [Online].